These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2938571)

  • 1. Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.
    Beatty WW; Butters N; Janowsky DS
    Behav Neural Biol; 1986 Mar; 45(2):196-211. PubMed ID: 2938571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling dementia: effects of scopolamine on memory and attention.
    Broks P; Preston GC; Traub M; Poppleton P; Ward C; Stahl SM
    Neuropsychologia; 1988; 26(5):685-700. PubMed ID: 3211287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model.
    Molchan SE; Martinez RA; Hill JL; Weingartner HJ; Thompson K; Vitiello B; Sunderland T
    Brain Res Brain Res Rev; 1992; 17(3):215-26. PubMed ID: 1467811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implicit, explicit, and semantic memory functions in Alzheimer's disease and Huntington's disease.
    Randolph C
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):479-94. PubMed ID: 1833416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks.
    Tröster AI; Fields JA; Testa JA; Paul RH; Blanco CR; Hames KA; Salmon DP; Beatty WW
    Neuropsychologia; 1998 Apr; 36(4):295-304. PubMed ID: 9665640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free recall and recognition in a network model of the hippocampus: simulating effects of scopolamine on human memory function.
    Hasselmo ME; Wyble BP
    Behav Brain Res; 1997 Dec; 89(1-2):1-34. PubMed ID: 9475612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients.
    Massman PJ; Delis DC; Butters N; Levin BE; Salmon DP
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):729-44. PubMed ID: 2147923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia.
    Robbins TW; Semple J; Kumar R; Truman MI; Shorter J; Ferraro A; Fox B; McKay G; Matthews K
    Psychopharmacology (Berl); 1997 Nov; 134(1):95-106. PubMed ID: 9399372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The subcortical dementia of Huntington's disease.
    Zakzanis KK
    J Clin Exp Neuropsychol; 1998 Aug; 20(4):565-78. PubMed ID: 9892059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group.
    Peavy G; Jacobs D; Salmon DP; Butters N; Delis DC; Taylor M; Massman P; Stout JC; Heindel WC; Kirson D
    J Clin Exp Neuropsychol; 1994 Aug; 16(4):508-23. PubMed ID: 7962355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is verbal recognition memory really different in Huntington's and Alzheimer's disease.
    Brandt J; Corwin J; Krafft L
    J Clin Exp Neuropsychol; 1992 Sep; 14(5):773-84. PubMed ID: 1474145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scopolamine effects on memory retention in mice: a model of dementia?
    Flood JF; Cherkin A
    Behav Neural Biol; 1986 Mar; 45(2):169-84. PubMed ID: 3964171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central anticholinergic hypersensitivity in aging.
    Ray PG; Meador KJ; Loring DW; Zamrini EW; Yang XH; Buccafusco JJ
    J Geriatr Psychiatry Neurol; 1992; 5(2):72-7. PubMed ID: 1317178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociations between skill learning and verbal recognition in amnesia and dementia.
    Martone M; Butters N; Payne M; Becker JT; Sax DS
    Arch Neurol; 1984 Sep; 41(9):965-70. PubMed ID: 6236779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory.
    Mewaldt SP; Ghoneim MM
    Pharmacol Biochem Behav; 1979 Feb; 10(2):205-10. PubMed ID: 450929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative analysis of scopolamine-induced amnesia.
    Caine ED; Weingartner H; Ludlow CL; Cudahy EA; Wehry S
    Psychopharmacology (Berl); 1981; 74(1):74-80. PubMed ID: 6791209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scopolamine does not disrupt spatial working memory in rats.
    Godding PR; Rush JR; Beatty WW
    Pharmacol Biochem Behav; 1982 Jun; 16(6):919-23. PubMed ID: 7111351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociative effects of scopolamine on working memory in healthy young volunteers.
    Rusted JM
    Psychopharmacology (Berl); 1988; 96(4):487-92. PubMed ID: 3149771
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.